Summary & Overview
CPT 86703: HIV-1 and HIV-2 Antibody Immunoassay, Single Assay
CPT code 86703 represents a laboratory immunoassay for the detection of HIV‑1 and HIV‑2 antibodies in a single assay, a critical tool in the diagnosis and screening of human immunodeficiency virus (HIV) infection. This code is widely used in clinical laboratories across the United States and is central to public health efforts aimed at early identification and management of HIV. The procedure is performed using multiple step methods, ensuring both qualitative and semiquantitative results that inform clinical decision-making.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, provide coverage for this service, reflecting its importance in routine and specialized care. Readers will gain insight into payer coverage, relevant clinical contexts, and associated coding benchmarks. The publication also addresses policy updates, common billing modifiers, and related laboratory codes, offering a comprehensive overview for stakeholders involved in laboratory operations, billing, and compliance.
Key topics include the clinical significance of HIV testing, payer landscape, and coding nuances. The summary provides a foundation for understanding how 86703 fits into broader HIV testing protocols and laboratory billing practices, supporting informed decision-making for healthcare organizations and professionals.
CPT Code Overview
CPT code 86703 is used to report qualitative or semiquantitative immunoassays performed by multiple step methods for the detection of HIV‑1 and HIV‑2 antibodies in a single assay. This procedure falls under Pathology and Laboratory Procedures – Immunology Procedures and is typically performed in a laboratory setting, such as a facility-based laboratory. The test is essential for identifying HIV infection status and is a cornerstone in both diagnostic and screening protocols for HIV.
Clinical & Coding Specifications
Clinical Context
A patient presents to a healthcare provider for evaluation of possible human immunodeficiency virus (HIV) infection. The provider orders laboratory testing to detect antibodies to both HIV-1 and HIV-2 using a single assay. The specimen is collected and sent to a clinical medical laboratory, where a qualitative or semiquantitative immunoassay is performed using multiple step methods. The results assist in diagnosing HIV infection, screening for HIV status, or evaluating inconclusive prior laboratory findings. This workflow is typical in settings such as routine screening, evaluation of exposure, or confirmation of HIV status in asymptomatic or symptomatic individuals.
Coding Specifications
-
Modifier
59: Distinct Procedural Service. Used when the immunoassay is performed separately from other procedures, indicating it is not bundled with other laboratory tests. -
Modifier
91: Repeat Clinical Diagnostic Laboratory Test. Used when the same immunoassay is performed more than once on the same patient on the same day, typically to confirm results or monitor changes.
| Provider Taxonomy Code | Specialty Description |
|---|---|
291U00000X |